Vertex Pharmaceuticals Inc | Business Operations | Business Contracts

Research, Development and Commercialization Agreement, dated as of May 24, 2004, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation Therapeutics... (Filed With SEC on November 3, 2021)

Amendment No. 1 to Research, Development and Commercialization Agreement, dated as of January 6, 2006, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)

Amendment No. 5 to Research, Development and Commercialization Agreement, effective as of April 1, 2011, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)

Amendment No. 7 to Research, Development and Commercialization Agreement, dated October 13, 2016, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)

Amended and Restated Joint Development and Commercialization Agreement, dated April 16, 2021, between Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited... (Filed With SEC on July 30, 2021)

Joint Development and Commercialization Agreement, dated December 12, 2017, between Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited and CRISPR... (Filed With SEC on February 11, 2021)

Vertex Pharmaceuticals Inc (27) | Business Operations (6)